Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vapotherm, originally founded as Rocky Mountain Medical Technologies, is a publicly traded medical technology company specializing in the development of non-invasive respiratory therapy devices. The company's flagship technology, High Velocity Nasal Insufflation (Hi-VNI), provides high-flow humidified oxygen to patients in respiratory distress, offering an alternative to more invasive ventilation methods. Vapotherm's products, such as the Precision Flow system, are widely used in hospitals and clinical settings to treat conditions like COPD, congestive heart failure, and neonatal respiratory distress. The company focuses on improving patient outcomes and reducing the need for intubation through advanced respiratory care solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rocky Mountain Medical.